Zhejiang Tianyu Pharmaceutical Balance Sheet Health
Financial Health criteria checks 4/6
Zhejiang Tianyu Pharmaceutical has a total shareholder equity of CN¥3.5B and total debt of CN¥1.7B, which brings its debt-to-equity ratio to 47.6%. Its total assets and total liabilities are CN¥6.4B and CN¥2.9B respectively. Zhejiang Tianyu Pharmaceutical's EBIT is CN¥92.8M making its interest coverage ratio 2.4. It has cash and short-term investments of CN¥495.2M.
Key information
47.6%
Debt to equity ratio
CN¥1.68b
Debt
| Interest coverage ratio | 2.4x |
| Cash | CN¥495.20m |
| Equity | CN¥3.53b |
| Total liabilities | CN¥2.90b |
| Total assets | CN¥6.43b |
Recent financial health updates
Recent updates
We Think Zhejiang Tianyu Pharmaceutical (SZSE:300702) Is Taking Some Risk With Its Debt
Nov 04
Concerns Surrounding Zhejiang Tianyu Pharmaceutical's (SZSE:300702) Performance
Sep 04Take Care Before Diving Into The Deep End On Zhejiang Tianyu Pharmaceutical Co., Ltd. (SZSE:300702)
Aug 21Further Upside For Zhejiang Tianyu Pharmaceutical Co., Ltd. (SZSE:300702) Shares Could Introduce Price Risks After 27% Bounce
May 21Zhejiang Tianyu Pharmaceutical Co., Ltd.'s (SZSE:300702) Revenues Are Not Doing Enough For Some Investors
Mar 17Financial Position Analysis
Short Term Liabilities: 300702's short term assets (CN¥3.0B) exceed its short term liabilities (CN¥2.6B).
Long Term Liabilities: 300702's short term assets (CN¥3.0B) exceed its long term liabilities (CN¥286.4M).
Debt to Equity History and Analysis
Debt Level: 300702's net debt to equity ratio (33.6%) is considered satisfactory.
Reducing Debt: 300702's debt to equity ratio has increased from 9% to 47.6% over the past 5 years.
Debt Coverage: 300702's debt is well covered by operating cash flow (25.3%).
Interest Coverage: 300702's interest payments on its debt are not well covered by EBIT (2.4x coverage).